Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 22.739.5620.4132.4710.29

What is the latest Core EBITDA Growth ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Growth ratio of SAKAR HEALTHCARE is 22.73 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202522.73
Mar20249.56
Mar202320.41
Mar202232.47
Mar202110.29

How is Core EBITDA Growth of SAKAR HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2025 22.73
137.76
Mar2024 9.56
-53.16
Mar2023 20.41
-37.14
Mar2022 32.47
215.55
Mar2021 10.29 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Growth ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹833.5 Cr 3.7% 6.4% 25.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,666.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 2.7% 0.4% 3.4% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

3.7%

6.4%

25.9%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses